BACKGROUND: Blood and plasma cannabinoid stability is important for test interpretation and is best studied in authentic rather than fortified samples. METHODS: Low and high blood and plasma pools were created for each of 10 participants after they smoked a cannabis cigarette. The stabilities of Δ(9)-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), 11-nor-9-carboxy-THC (THCCOOH), cannabidiol (CBD), cannabinol (CBN), THC-glucuronide, and THCCOOH-glucuronide were determined after 1 week at room temperature; 1, 2, 4, 12, and 26 (±2) weeks at 4 °C; and 1, 2, 4, 12, 26 (±2), and 52 (±4) weeks at -20 °C. Stability was assessed by Friedman test. RESULTS: Numbers of THC-glucuronide and CBD-positive blood samples were insufficient to assess stability. In blood, 11-OH-THC and CBN were stable for 1 week at room temperature, whereas THC and THCCOOH-glucuronide decreased and THCCOOH increased. In blood, THC, THCCOOH-glucuronide, THCCOOH, 11-OH-THC, and CBN were stable for 12, 4, 4, 12, and 26 weeks, respectively, at 4 °C and 12, 12, 26, 26, and 52 weeks at -20 °C. In plasma, THC-glucuronide, THC, CBN, and CBD were stable for 1 week at room temperature, whereas THCCOOH-glucuronide and 11-OH-THC decreased and THCCOOH increased. In plasma, THC-glucuronide, THC, THCCOOH-glucuronide, THCCOOH, 11-OH-THC, CBN, and CBD were stable for 26, 26, 2, 2, 26, 12, and 26 weeks, respectively, at 4 °C and 52, 52, 26, 26, 52, 52, and 52 weeks, respectively, at -20 °C. CONCLUSIONS: Blood and plasma samples should be stored at -20 °C for no more than 3 and 6 months, respectively, to assure accurate cannabinoid quantitative results.
BACKGROUND: Blood and plasma cannabinoid stability is important for test interpretation and is best studied in authentic rather than fortified samples. METHODS: Low and high blood and plasma pools were created for each of 10 participants after they smoked a cannabis cigarette. The stabilities of Δ(9)-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), 11-nor-9-carboxy-THC (THCCOOH), cannabidiol (CBD), cannabinol (CBN), THC-glucuronide, and THCCOOH-glucuronide were determined after 1 week at room temperature; 1, 2, 4, 12, and 26 (±2) weeks at 4 °C; and 1, 2, 4, 12, 26 (±2), and 52 (±4) weeks at -20 °C. Stability was assessed by Friedman test. RESULTS: Numbers of THC-glucuronide and CBD-positive blood samples were insufficient to assess stability. In blood, 11-OH-THC and CBN were stable for 1 week at room temperature, whereas THC and THCCOOH-glucuronide decreased and THCCOOH increased. In blood, THC, THCCOOH-glucuronide, THCCOOH, 11-OH-THC, and CBN were stable for 12, 4, 4, 12, and 26 weeks, respectively, at 4 °C and 12, 12, 26, 26, and 52 weeks at -20 °C. In plasma, THC-glucuronide, THC, CBN, and CBD were stable for 1 week at room temperature, whereas THCCOOH-glucuronide and 11-OH-THC decreased and THCCOOH increased. In plasma, THC-glucuronide, THC, THCCOOH-glucuronide, THCCOOH, 11-OH-THC, CBN, and CBD were stable for 26, 26, 2, 2, 26, 12, and 26 weeks, respectively, at 4 °C and 52, 52, 26, 26, 52, 52, and 52 weeks, respectively, at -20 °C. CONCLUSIONS: Blood and plasma samples should be stored at -20 °C for no more than 3 and 6 months, respectively, to assure accurate cannabinoid quantitative results.
Authors: Matthew J Smith; Eva C Alden; Amy A Herrold; Andrea Roberts; Dan Stern; Joseph Jones; Allan Barnes; Kailyn P O'Connor; Marilyn A Huestis; Hans C Breiter Journal: J Stud Alcohol Drugs Date: 2018-05 Impact factor: 2.582
Authors: David M Andrenyak; David E Moody; Matthew H Slawson; Daniel S O'Leary; Margaret Haney Journal: J Anal Toxicol Date: 2017-05-01 Impact factor: 3.367
Authors: Rebecca L Hartman; Timothy L Brown; Gary Milavetz; Andrew Spurgin; Russell S Pierce; David A Gorelick; Gary Gaffney; Marilyn A Huestis Journal: Drug Alcohol Depend Date: 2015-06-23 Impact factor: 4.492
Authors: Erin L Karschner; Madeleine J Swortwood; Jussi Hirvonen; Robert S Goodwin; Wendy M Bosker; Johannes G Ramaekers; Marilyn A Huestis Journal: Drug Test Anal Date: 2015-06-11 Impact factor: 3.345
Authors: Jelena Klawitter; Cristina Sempio; Sophie Mörlein; Erik De Bloois; Jacek Klepacki; Thomas Henthorn; Maureen A Leehey; Edward J Hoffenberg; Kelly Knupp; George S Wang; Christian Hopfer; Greg Kinney; Russell Bowler; Nicholas Foreman; Jeffrey Galinkin; Uwe Christians; Jost Klawitter Journal: Ther Drug Monit Date: 2017-10 Impact factor: 3.681
Authors: Nathalie A Desrosiers; Dayong Lee; Karl B Scheidweiler; Marta Concheiro-Guisan; David A Gorelick; Marilyn A Huestis Journal: Anal Bioanal Chem Date: 2013-12-01 Impact factor: 4.142
Authors: Rebecca L Hartman; Timothy L Brown; Gary Milavetz; Andrew Spurgin; David A Gorelick; Gary Gaffney; Marilyn A Huestis Journal: Drug Test Anal Date: 2015-08-10 Impact factor: 3.345
Authors: Alyson H Fitzgerald; Yuntao Zhang; Scott Fritz; William H Whitehouse; Tamera Brabson; Lisa Pohlman; Natalia Cernicchiaro; Caroline Tonozzi; Steve Ensley Journal: J Vet Diagn Invest Date: 2021-07-10 Impact factor: 1.569